Unknown

Dataset Information

0

Effects of the Antimicrobial Peptide LL-37 and Innate Effector Mechanisms in Colistin-Resistant Klebsiella pneumoniae With mgrB Insertions.


ABSTRACT: Background:Colistin is a polypeptide antibiotic drug that targets lipopolysaccharides in the outer membrane of Gram-negative bacteria. Inactivation of the mgrB-gene is a common mechanism behind colistin-resistance in Klebsiella pneumoniae (Kpn). Since colistin is a cyclic polypeptide, it may exhibit cross-resistance with the antimicrobial peptide LL-37, and with other innate effector mechanisms, but previous results are inconclusive. Objective:To study potential cross-resistance between colistin and LL-37, as well as with other innate effector mechanisms, and to compare virulence of colistin-resistant and susceptible Kpn strains. Materials/Methods:Carbapenemase-producing Kpn from Oman (n = 17) were subjected to antimicrobial susceptibility testing and whole genome sequencing. Susceptibility to colistin and LL-37 was studied. The surface charge was determined by zeta-potential measurements and the morphology of treated bacteria was analyzed with electron microscopy. Bacterial survival was assessed in human whole blood and serum, as well as in a zebrafish infection-model. Results:Genome-analysis revealed insertion-sequences in the mgrB gene, as a cause of colistin resistance in 8/17 isolates. Colistin-resistant (Col-R) isolates were found to be more resistant to LL-37 compared to colistin-susceptible (Col-S) isolates, but only at concentrations ?50 ?g/ml. There was no significant difference in surface charge between the isolates. The morphological changes were similar in both Col-R and Col-S isolates after exposure to LL-37. Finally, no survival difference between the Col-R and Col-S isolates was observed in whole blood or serum, or in zebrafish embryos. Conclusion:Cross-resistance between colistin and LL-37 was observed at elevated concentrations of LL-37. However, Col-R and Col-S isolates exhibited similar survival in serum and whole blood, and in a zebrafish infection-model, suggesting that cross-resistance most likely play a limited role during physiological conditions. However, it cannot be ruled out that the observed cross-resistance could be relevant in conditions where LL-37 levels reach high concentrations, such as during infection or inflammation.

SUBMITTER: Al-Farsi HM 

PROVIDER: S-EPMC6870453 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Effects of the Antimicrobial Peptide LL-37 and Innate Effector Mechanisms in Colistin-Resistant <i>Klebsiella pneumoniae</i> With <i>mgrB</i> Insertions.

Al-Farsi Hissa M HM   Al-Adwani Salma S   Ahmed Sultan S   Vogt Carmen C   Ambikan Anoop T AT   Leber Anna A   Al-Jardani Amina A   Al-Azri Saleh S   Al-Muharmi Zakariya Z   Toprak Muhammet S MS   Giske Christian G CG   Bergman Peter P  

Frontiers in microbiology 20191114


<h4>Background</h4>Colistin is a polypeptide antibiotic drug that targets lipopolysaccharides in the outer membrane of Gram-negative bacteria. Inactivation of the <i>mgrB</i>-gene is a common mechanism behind colistin-resistance in <i>Klebsiella pneumoniae</i> (Kpn). Since colistin is a cyclic polypeptide, it may exhibit cross-resistance with the antimicrobial peptide LL-37, and with other innate effector mechanisms, but previous results are inconclusive.<h4>Objective</h4>To study potential cros  ...[more]

Similar Datasets

| S-EPMC5741654 | biostudies-literature
| S-EPMC7143398 | biostudies-literature
| S-EPMC10314893 | biostudies-literature
| S-EPMC4187966 | biostudies-literature
| S-EPMC8796155 | biostudies-literature
| S-EPMC2916318 | biostudies-literature
2020-03-19 | PXD016511 | Pride
| S-EPMC4572530 | biostudies-literature
| S-EPMC9334626 | biostudies-literature
| S-EPMC6101004 | biostudies-literature